Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

9480	Companies
185562	Keywords
117961	Articles
99395	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 04/09/2025 at 07:00, 7 months 26 days ago

Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity
Biophytis confirms the Phase 2 OBA Clinical Trial launch in obesity, continuing development of BIO101 to reduce muscle strength loss. Seeking pharmaceutical partner for co-development

Biophytis BIO101 Obesity Pharmaceutical Partner Phase 2 OBA Clinical Trial
PRESS RELEASE

published on 04/09/2025 at 06:59, 7 months 26 days ago

Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity
Biophytis confirms the launch of the Phase 2 OBA Clinical Trial in Obesity in 2025. The study aims to evaluate the efficacy of BIO101 in reducing muscle strength loss caused by GLP-1 agonists in obese patients

Biophytis BIO101 Obesity Muscle Strength Phase 2 OBA Clinical Trial
BRIEF

published on 03/28/2025 at 22:05, 8 months 8 days ago

Biophytis finalise un placement privé de 2,6 millions d'euros

Biophytis Biotechnologie Placement Privé Euronext Growth Actions Nouvelles
BRIEF

published on 03/28/2025 at 22:05, 8 months 8 days ago

Biophytis Finalizes €2.6 Million Private Placement

Private Placement Biophytis Warrants New Shares Euronext Growth
REGULATED PRESS RELEASE

published on 03/28/2025 at 22:00, 8 months 8 days ago

Biophytis announces the settlement and delivery of its €2.6 million private placement
Biophytis announces the settlement and delivery of its €2.6 million private placement. New shares admitted for trading on Euronext Growth. Maxim Group LLC and Invest Securities involved in the transaction

Private Placement Biophytis Euronext Growth Maxim Group LLC Settlement
REGULATED PRESS RELEASE

published on 03/28/2025 at 22:00, 8 months 8 days ago

Biophytis annonce le règlement-livraison de son placement privé de 2,6 millions d'euros
Biophytis annonce le règlement-livraison de son placement privé de 2,6 millions d'euros. Les actions seront cotées sur Euronext Growth. Maxim Group LLC et Invest Securities ont agi en tant qu'agents de placement

Biophytis Placement Privé Euronext Growth INVEST SECURITIES Maxim Group LLC
PRESS RELEASE

published on 03/28/2025 at 21:59, 8 months 8 days ago

Biophytis annonce le règlement-livraison de son placement privé de 2,6 millions d'euros
Biophytis annonce le règlement-livraison de son placement privé de 2,6 millions d'euros. Actions nouvelles admises à Euronext Growth Paris

Euronext Growth Paris Biophytis Placement Privé Actions Nouvelles 2,6 Millions D'euros
PRESS RELEASE

published on 03/28/2025 at 21:59, 8 months 8 days ago

Biophytis announces the settlement and delivery of its €2.6 million private placement
Biophytis settles €2.6 million private placement, issuing new shares and warrants. Company specializes in age-related disease treatments

Private Placement Biophytis Warrants New Shares Age-related Diseases
BRIEF

published on 03/26/2025 at 07:40, 8 months 10 days ago

Biophytis Completes €2.6 Million Private Placement

Private Placement Biophytis Trading Capital Increase Clinical Programs
BRIEF

published on 03/26/2025 at 07:40, 8 months 10 days ago

Biophytis réussit un placement privé de 2,6 millions d'euros

Biophytis Actions Placement Privé Capital Investissement Sarcopénie

Accesswire

Published on 12/05/2025 at 22:50, 36 minutes ago

Banyan Gold Grants Incentive Stock Options
Published on 12/05/2025 at 21:45, 1 hour 41 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 1 hour 56 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 2 hours 6 minutes ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 2 hours 26 minutes ago

The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 1 hour 11 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 1 hour 14 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 4 hours 28 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 5 hours ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 5 hours 11 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 26 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 26 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 26 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 26 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 6 hours 8 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE